Recruiting

SOGI Data Collection

Sponsor:

Pacific Institute for Research and Evaluation

Code:

NCT07904078

Conditions

Implementation Strategies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Training

Implementation Strategy 1

Implementation Strategy 2

Study Details

Brief summary:

Collecting and using sexual orientation and gender identity (SOGI) data are the keys to systematically assessing and addressing the health and healthcare needs of sexual- and gender-diverse (SGD) people across all domains of life. This multilevel, mixed-method study will develop resources and study strategies for implementing SOGI data collection in state-operated Public Health Offices that provide a wide range of health and social services to racially, ethnically, and geographically diverse communities in urban, rural, and frontier communities of New Mexico. Study findings will be pertinent to other states and healthcare settings interested in illuminating the nature and extent of disparities and adverse health outcomes for SGD people, encouraging patient-centered care, and advancing equity-focused evidence-based interventions to eliminate long-standing disparities.

Conditions

Implementation Strategies

Study ID

NCT07904078

Start date

Nov, 2026

Status verified date

Oct, 2026

Completion date

Jun, 2030

Anticipated

Primary completion date

Jul, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion criteria for NMHealth/PHO professionals in Aims 1 and 3:

  • Being age 18 or older;
  • Current employment at NMHealth/PHO of at least six months at 20 hours per week or more;
  • Being proficient in English to complete study instrumentation and informed consent; and
  • Being able to provide informed consent.

Inclusion criteria for NMHealth/PHO professionals in Aim 2:

  • Being age 18 or older;
  • Current employment at NMHealth/PHO at 20 hours per week or more;
  • Being proficient in English to complete study instrumentation and informed consent; and
  • Being able to provide informed consent.

Inclusion criteria for PHO patients in Aim 1:

  • Being age 18 and over;
  • Being proficient in English or Spanish to complete study instrumentation and informed consent;
  • Being able to provide informed consent; and
  • Having used PHO services within the last six months.

Inclusion criteria for PHO patients in Aim 2:

  • Being age 18 and over;
  • Being proficient in English or Spanish to complete study instrumentation and informed consent;
  • Being able to provide informed consent; and
  • Having visited a PHO in the past month.

Study Design

Enrollment

1320 participants

Anticipated

Allocation

Randomized

Intervention Model

Sequential

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Training Alone - 1

Public Health Offices (PHOs) in this arm receive training in phase 1 (months 1-4).

PHOs are then randomized to continue training in phase 2 (months 5-10). Due to responding to training only, PHOs continue with training only through phase 3 (months 11-16). In phase 4 (months 17-22), implementation support is discontinued.

experimental: Training Alone - 2

Public Health Offices (PHOs) in this arm receive training in phase 1 (months 1-4).

PHOs are then randomized to continue training in phase 2 (months 5-10). Due to not responding to training only, PHOs are randomized to continue with training only through phase 3 (months 11-16). In phase 4 (months 17-22), implementation support is discontinued.

experimental: Training + Implementation Strategy 2

Public Health Offices (PHOs) in this arm receive training in phase 1 (months 1-4).

PHOs are then randomized to continue training in phase 2 (months 5-10). Due to not responding to training only, PHOs are randomized to continue with training and to receive an additional implementation strategy (implementation strategy 2) through phase 3 (months 11-16). In phase 4 (months 17-22), implementation support is discontinued.

experimental: Training and Implementation Strategy 1-1

Public Health Offices (PHOs) in this arm receive training in phase 1 (months 1-4).

PHOs are then randomized to continue training and receive an additional implementation strategy (implementation strategy 1) in phase 2 (months 5-10). Due to responding to training and implementation strategy 1, PHOs continue with training and implementation strategy 1 through phase 3 (months 11-16). In phase 4 (months 17-22), implementation support is discontinued.

experimental: Training and Implementation Strategy 1-2

Public Health Offices (PHOs) in this arm receive training in phase 1 (months 1-4).

PHOs are then randomized to continue training and receive an additional implementation strategy (implementation strategy 1) in phase 2 (months 5-10). Due to not responding to training and implementation strategy 1, PHOs continue with training and implementation strategy 1 through phase 3 (months 11-16). In phase 4 (months 17-22), implementation support is discontinued.

experimental: Training + Implementation Strategies 1 and 2

Public Health Offices (PHOs) in this arm receive training in phase 1 (months 1-4).

PHOs are then randomized to continue training and receive an additional implementation strategy (implementation strategy 1) in phase 2 (months 5-10). Due to not responding to training and implementation strategy 1, PHOs are randomized to continue with training and implementation strategy 1 and to receive an additional implementation strategy (implementation strategy 2) through phase 3 (months 11-16). In phase 4 (months 17-22), implementation support is discontinued.

Interventions

Training

Brief training on demographic data collection and entry for PHO staff.

Implementation Strategy 1

Implementation support strategy identified through implementation mapping.

Implementation Strategy 2

Implementation support strategy identified through implementation mapping.

Primary outcome measure

  • Adoption - Electronic Health Records (EHR) [ Time Frame: Prior to randomization; then 4, 10, 16, and 22 months post initial randomization. ]

Central Contacts and Locations

Central contacts

Daniel Shattuck

505-765-2331dshattuck@pire.org

Locations

Pacific Institute for Research and Evaluation

Recruiting

Albuquerque, New Mexico, United States, 87106

Contacts

Daniel Shattuck

505-765-2331dshattuck@pire.org

More Information

Sponsor

Pacific Institute for Research and Evaluation

Last update posted

Oct 29, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-30. This information was provided to ClinicalTrials.gov by Pacific Institute for Research and Evaluation on 2026-10-29. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.